These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
361 related items for PubMed ID: 18201154
1. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol for contraception and control of menstrual symptoms. Jensen JT, Archer DF. Expert Opin Pharmacother; 2008 Feb; 9(2):319-27. PubMed ID: 18201154 [Abstract] [Full Text] [Related]
6. Levonorgestrel versus the "Yuzpe" regimen. New choices in emergency contraception. Lee SM, Dunn S, Evans MF. Can Fam Physician; 1999 Mar; 45():629-31. PubMed ID: 10099801 [Abstract] [Full Text] [Related]
9. Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen. Weisberg E, Brache V, Alvarez F, Massai R, Mishell DR, Apter D, Gale J, Sivin I, Tsong YY, Fraser IS. Contraception; 2005 Jul; 72(1):46-52. PubMed ID: 15964292 [Abstract] [Full Text] [Related]
10. Bioavailability of the Yuzpe and levonorgestrel regimens of emergency contraception: vaginal vs. oral administration. Kives S, Hahn PM, White E, Stanczyk FZ, Reid RL. Contraception; 2005 Mar; 71(3):197-201. PubMed ID: 15722070 [Abstract] [Full Text] [Related]
11. Endometrial histology following 1 year of a continuous daily regimen of levonorgestrel 90 micro g/ethinyl estradiol 20 micro g. Johnson JV, Grubb GS, Constantine GD. Contraception; 2007 Jan; 75(1):23-6. PubMed ID: 17161119 [Abstract] [Full Text] [Related]
13. Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse). Barbosa IC, Filho CI, Faggion D, Baracat EC. Contraception; 2006 Jan; 73(1):30-3. PubMed ID: 16371291 [Abstract] [Full Text] [Related]
14. A continuous regimen of levonorgestrel/ethinyl estradiol for contraception and elimination of menstruation. Jensen JT. Drugs Today (Barc); 2008 Mar; 44(3):183-95. PubMed ID: 18536780 [Abstract] [Full Text] [Related]
17. Comparison of cycle control and side effects between transdermal contraceptive patch and an oral contraceptive in women older than 35 years. Boonyarangkul A, Taneepanichskul S. J Med Assoc Thai; 2007 Sep; 90(9):1715-9. PubMed ID: 17957909 [Abstract] [Full Text] [Related]
18. Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception. Rose S, Chaudhari A, Peterson CM. Adv Drug Deliv Rev; 2009 Aug 10; 61(10):808-12. PubMed ID: 19445984 [Abstract] [Full Text] [Related]
19. Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol. Anderson FD, Gibbons W, Portman D. Contraception; 2006 Mar 10; 73(3):229-34. PubMed ID: 16472561 [Abstract] [Full Text] [Related]
20. Treatment of menstrual disorders with a combination of norgestrel and ethynyl estradiol. Rao KP. Curr Med Pract; 1971 Mar 10; 15(1):586-9. PubMed ID: 12306340 [Abstract] [Full Text] [Related] Page: [Next] [New Search]